Aethon Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $30M

  • Investors
  • 2

Aethon Therapeutics General Information

Description

Developer of a cancer immunotherapy platform intended to create neoantigens by design, to transform cancer treatments into cures. The company offers a proprietary technology that combines engineered antibodies with immune therapies to mount immune attacks to selectively kill residual cancer cells, including drug-resistant persister cells, enabling oncologists to target drug-resistant cancer cells more effectively, potentially transforming cancer treatments into cures.

Contact Information

Website
www.aethontx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30-02 48th Avenue
  • Suite 280
  • Long Island City, NY 11101
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 30-02 48th Avenue
  • Suite 280
  • Long Island City, NY 11101
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aethon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 09-Jan-2023 $30M Completed Startup
To view Aethon Therapeutics’s complete valuation and funding history, request access »

Aethon Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Aethon Therapeutics’s complete cap table history, request access »

Aethon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cancer immunotherapy platform intended to create neoantigens by design, to transform cancer treatments in
Drug Discovery
Long Island City, NY
15 As of 2026

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aethon Therapeutics Competitors (1)

One of Aethon Therapeutics’s competitors is Clasp Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clasp Therapeutics Venture Capital-Backed Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

Aethon Therapeutics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Aethon Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025250756-A2 Compositions and methods for binding to covalent peptide conjugates containing divarasib Pending 30-May-2024
WO-2025250756-A3 Compositions and methods for binding to covalent peptide conjugates containing divarasib Pending 30-May-2024
WO-2025226775-A2 Compositions and methods for binding to covalent peptide conjugates Pending 23-Apr-2024
WO-2025226775-A3 Compositions and methods for binding to covalent peptide conjugates Pending 23-Apr-2024 C07K16/2833

Aethon Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aethon Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apple Tree Partners (ATP) Venture Capital Minority
NYU Langone Health Corporation Minority
To view Aethon Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Aethon Therapeutics FAQs

  • When was Aethon Therapeutics founded?

    Aethon Therapeutics was founded in 2022.

  • Where is Aethon Therapeutics headquartered?

    Aethon Therapeutics is headquartered in Long Island City, NY.

  • What is the size of Aethon Therapeutics?

    Aethon Therapeutics has 15 total employees.

  • What industry is Aethon Therapeutics in?

    Aethon Therapeutics’s primary industry is Drug Discovery.

  • Is Aethon Therapeutics a private or public company?

    Aethon Therapeutics is a Private company.

  • What is the current valuation of Aethon Therapeutics?

    The current valuation of Aethon Therapeutics is .

  • What is Aethon Therapeutics’s current revenue?

    The current revenue for Aethon Therapeutics is .

  • How much funding has Aethon Therapeutics raised over time?

    Aethon Therapeutics has raised $30M.

  • Who are Aethon Therapeutics’s investors?

    Apple Tree Partners (ATP) and NYU Langone Health have invested in Aethon Therapeutics.

  • Who are Aethon Therapeutics’s competitors?

    Clasp Therapeutics is a competitor of Aethon Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process